ইস্রায়েল - ইংরেজি - Ministry of Health

sanofi - aventis israel ltd - agalsidase beta 5 mg/ml - powder for concentrate for infusion - agalsidase beta - long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease.

ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

zuellig pharma corp - agalsidase beta - powder for concentrate solution for i.v. infusion - 5mg

ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

zuellig pharma corp - agalsidase beta - powder for concentrate solution for iv infusion - 35mg

ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

genzyme corp - usa; importer: sanofi-aventis philippines, inc. - agalsidase beta - powder for concentrate solution for i.v. infusion - 5 mg

ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

n/a; importer: sanofi-aventis philippines, inc.; distributor: n/a - agalsidase beta - powder for concentrate for solution for infusion (iv) - 35 mg

সাউদি আরব - ইংরেজি - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

genzyme europe b.v., netherlands - agalsidase beta - powder for concentrate for solution for infusion - 5 mg/ml

সাউদি আরব - ইংরেজি - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

genzyme europe b.v., netherlands - agalsidase beta - powder for concentrate for solution for infusion - 5 mg/ml

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

genzyme australasia pty ltd - agalsidase beta -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

genzyme australasia pty ltd - agalsidase beta -

মাল্যাশিয়া - ইংরেজি - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - recombinant human alfa galactosidase (r-hagal) -